In China, Rare Dissent Over a Program to Save on Drug Costs

A rare display of public anger is unfolding in China over the quality of domestically produced drugs, with prominent doctors raising concerns about anesthetics, blood pressure medication, and potential fraud by domestic drugmakers. The pushback stems from Beijing’s efforts to lower medical costs by favoring cheaper drugs, leading to decreased prices but potentially compromising drug quality. Doctors are calling for changes to allow patients to pay more for alternative drugs, as the focus on generics has limited access to foreign branded medications and raised questions about the efficacy and safety of domestic drugs in public hospitals.

Full Article